Marchex (NASDAQ:MCHX – Get Free Report) announced its earnings results on Wednesday. The technology company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02), FiscalAI reports. Marchex had a negative net margin of 11.53% and a negative return on equity of 15.14%. The firm had revenue of $10.62 million during the quarter, compared to analyst estimates of $10.89 million.
Here are the key takeaways from Marchex’s conference call:
- Marchex said it believes it is at a positive inflection point, with better execution, rising penetration in its customer base, and early signs that its AI strategy is creating sales momentum.
- The company reported Q1 2026 revenue of $10.6 million, with new sales and upsells partly offset by migration-related revenue pressure from moving legacy platforms to Marchex Engage.
- Management raised near-term expectations, guiding Q2 adjusted EBITDA to $1.6 million-$1.8 million and saying Q3 could reach about $2 million or more on a standalone basis, or $2.5 million or more if the Archenia deal closes.
- Marchex and Archenia are already jointly selling early AI-based products, and management said nearly half of the top customers pitched have already bought one or more offerings on a recurring or pilot basis.
- The company expects the pending Archenia acquisition to close in July 2026, pending stockholder approval, and says the combination could expand its addressable market, lift margins, and support a longer-term revenue run rate of about $60 million annually.
Marchex Trading Up 1.3%
NASDAQ MCHX traded up $0.02 during mid-day trading on Thursday, reaching $1.62. 21,337 shares of the company’s stock traded hands, compared to its average volume of 16,371. Marchex has a 1-year low of $1.32 and a 1-year high of $2.31. The company has a fifty day simple moving average of $1.55 and a 200-day simple moving average of $1.61. The company has a market cap of $71.13 million, a price-to-earnings ratio of -13.50 and a beta of 1.95.
Analysts Set New Price Targets
Get Our Latest Report on Marchex
Institutional Trading of Marchex
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. XTX Topco Ltd bought a new position in Marchex during the 4th quarter valued at $26,000. Jane Street Group LLC bought a new stake in shares of Marchex in the 1st quarter worth about $30,000. Manatuck Hill Partners LLC acquired a new stake in shares of Marchex in the 2nd quarter valued at about $88,000. Finally, Kanen Wealth Management LLC acquired a new stake in shares of Marchex in the 1st quarter valued at about $813,000. Institutional investors own 73.46% of the company’s stock.
About Marchex
Marchex, Inc (NASDAQ: MCHX) operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company’s core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.
Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.
Featured Articles
- Five stocks we like better than Marchex
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.
